πŸ“Š Biopharmaceutics and Pharmacokinetic
Q. Which one of these is correct Michaelis-Menten equation?
  • (A) –dC/dt = Vmax C/Km+C
  • (B) dC/dt = Vmax C/Km+C
  • (C) –dC/dt = Vmax C/Km
  • (D) –dC/dt = Km+C / Vmax C
πŸ’¬ Discuss
βœ… Correct Answer: (A) –dC/dt = Vmax C/Km+C
πŸ“Š Biopharmaceutics and Pharmacokinetic
Q. Which of the following creates nonlinearity in drug distribution and not in drug absorption?
  • (A) When absorption is solubility or dissolution rate-limited
  • (B) When absorption involves carrier-mediated transport systems
  • (C) When a presystemic gut wall or hepatic metabolism attains saturation
  • (D) Saturation of binding sites on plasma proteins
πŸ’¬ Discuss
βœ… Correct Answer: (D) Saturation of binding sites on plasma proteins
πŸ“Š Biopharmaceutics and Pharmacokinetic
Q. Any changes in fraction bioavailable, elimination half-life indicates nonlinearity of that particular drug.
  • (A) True
  • (B) False
  • (C) none
  • (D) all
πŸ’¬ Discuss
βœ… Correct Answer: (A) True
πŸ“Š Biopharmaceutics and Pharmacokinetic
Q. Name the different methods used to estimate Km and Vmax graphically.
  • (A) Direct Linear plot
  • (B) Lineweaver —Burke plot or Klotz Plot
  • (C) Graphical Method
  • (D) All of the above
πŸ’¬ Discuss
βœ… Correct Answer: (D) All of the above
πŸ“Š Biopharmaceutics and Pharmacokinetic
Q. In Michaelis-Menton Equation, When the value of Km = C
  • (A) rate of process is half (1 /2) the maximum rate.
  • (B) the elimination of most drugs follows first order kinetic
  • (C) the elimination of most drugs follows zero order kinetic
  • (D) the elimination of most drugs follows second order kinetic
πŸ’¬ Discuss
βœ… Correct Answer: (A) rate of process is half (1 /2) the maximum rate.
πŸ“Š Biopharmaceutics and Pharmacokinetic
Q. Which of the following Factors causing Non-linearity?
  • (A) Nonlinearity may arise due to pathological alteration at any one of the various pharmacokinetic steps, such as absorption, distribution and/or elimination.
  • (B) Nonlinearity may arise due to Capacity-limited metabolism.
  • (C) Nonlinearity may arise due to alteration in protein binding characteristics
  • (D) All of the above
πŸ’¬ Discuss
βœ… Correct Answer: (D) All of the above
πŸ“Š Biopharmaceutics and Pharmacokinetic
Q. Which of the following is correct statement about Nonlinear pharmacokinetics?
  • (A) The pharmacokinetic parameters of a drug will not change when multiple doses of drug are administered
  • (B) The graph of the relationship between the different factors involved (dose, blood plasma concentrations, elimination, etc.) gives a straight line.
  • (C) the plasma drug concentration changes either more or less than would be expected from a change in dose rate.
  • (D) None of the above
πŸ’¬ Discuss
βœ… Correct Answer: (C) the plasma drug concentration changes either more or less than would be expected from a change in dose rate.
πŸ“Š Biopharmaceutics and Pharmacokinetic
Q. …………..it is the extent to which a drug will accumulate relative to the first dose can be quantified by an accumulation factor R.
  • (A) Accumulation Index
  • (B) Apparent volume of drug distribution
  • (C) Accumulation factor
  • (D) None of the above
πŸ’¬ Discuss
βœ… Correct Answer: (A) Accumulation Index
πŸ“Š Biopharmaceutics and Pharmacokinetic
Q. If the steady-state plasma concentration is directly proportional to the dose, then ……….in the kinetics exists.
  • (A) Linearity
  • (B) Non-linearity
  • (C) Both of the above
  • (D) None of the above
πŸ’¬ Discuss
βœ… Correct Answer: (A) Linearity
πŸ“Š Biopharmaceutics and Pharmacokinetic
Q. Linear Pharmacokinetics also referred as………….
  • (A) First-order kinetics
  • (B) Second order kinetics
  • (C) Pseudo order kinetics
  • (D) None of the above in
πŸ’¬ Discuss
βœ… Correct Answer: (A) First-order kinetics